Dare Bioscience, Inc. Prepaid Expense, Current
Dare Bioscience, Inc. (DARE) had Prepaid Expense, Current of $835.42 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Prepaid Expense, Current
us-gaap:PrepaidExpenseCurrent · last filed 2026-08-13
- 2026-06-30: Prepaid Expense, Current $835.42K.
- 2026-03-31: Prepaid Expense, Current $680.75K.
- 2025-12-31: Prepaid Expense, Current $387.09K; Prepaid Expense, Current as first filed $2.35M.
- 2025-09-30: Prepaid Expense, Current $1.51M.
| Period end | Prepaid Expense, Current | Prepaid Expense, Current as first filed |
|---|---|---|
| 2026-06-30 | $835.42K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $680.75K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $387.09K 10-Q · filed 2026-08-13 | $2.35M 10-K · filed 2026-03-26 |
| 2025-09-30 | $1.51M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $1.38M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.39M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $2.75M 10-K · filed 2026-03-26 | $2.52M 10-K · filed 2025-03-31 |
| 2024-09-30 | $3.19M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $3.51M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $4.81M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $6.12M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $6.58M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $8.07M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $7.08M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $6.67M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $6.89M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $5.90M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $6.77M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $2.48M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $2.52M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $1.99M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $1.64M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $1.85M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $1.38M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $2.25M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $3.84M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $1.11M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $770.51K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $437.96K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $588.52K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $403.10K 10-K · filed 2020-03-27 | |
| 2018-09-30 | $549.95K 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $347.41K 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $290.88K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $311.57K 10-K · filed 2019-04-01 | |
| 2015-12-31 | $250.00K 8-K/A · filed 2017-10-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |